Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133914) titled 'Comparative effectiveness of prophylactic versus therapeutic use of PEG-rhG-CSF in patients with locally advanced nasopharyngeal carcinoma: a prospective cohort study(WBC-NPC 01)' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Third Xiangya Hospital Central South University
Condition:
Locally advanced nasopharyngeal carcinoma
Intervention:
Control group (therapeutic use of PEG-rhG-CSF strategy):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-12
Target Sample Size: Control group (therapeutic use of PEG-rhG-CSF strategy):...